Mercer Global Advisors’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $776K | Sell |
36,452
-943
| -3% | -$20.1K | ﹤0.01% | 1306 |
|
|
2025
Q1 | $721K | Sell |
37,395
-7,283
| -16% | -$140K | ﹤0.01% | 1291 |
|
|
2024
Q4 | $797K | Sell |
44,678
-131
| -0.3% | -$2.34K | ﹤0.01% | 1211 |
|
|
2024
Q3 | $901K | Sell |
44,809
-2,442
| -5% | -$49.1K | ﹤0.01% | 1058 |
|
|
2024
Q2 | $369K | Sell |
47,251
-1,951
| -4% | -$15.2K | ﹤0.01% | 1475 |
|
|
2024
Q1 | $204K | Buy |
49,202
+902
| +2% | +$3.74K | ﹤0.01% | 1776 |
|
|
2023
Q4 | $126K | Hold |
48,300
| – | – | ﹤0.01% | 1892 |
|
|
2023
Q3 | $90K | Hold |
48,300
| – | – | ﹤0.01% | 1861 |
|
|
2023
Q2 | $121K | Buy |
48,300
+5,200
| +12% | +$13K | ﹤0.01% | 1809 |
|
|
2023
Q1 | $75K | Hold |
43,100
| – | – | ﹤0.01% | 1845 |
|
|
2022
Q4 | $183K | Buy |
43,100
+800
| +2% | +$3.4K | ﹤0.01% | 1729 |
|
|
2022
Q3 | $50K | Buy |
42,300
+2,100
| +5% | +$2.48K | ﹤0.01% | 1769 |
|
|
2022
Q2 | $40K | Buy |
40,200
+15,300
| +61% | +$15.2K | ﹤0.01% | 1777 |
|
|
2022
Q1 | $61K | Buy |
24,900
+2,950
| +13% | +$7.23K | ﹤0.01% | 1829 |
|
|
2021
Q4 | $59K | Buy |
21,950
+4,000
| +22% | +$10.8K | ﹤0.01% | 1740 |
|
|
2021
Q3 | $90K | Hold |
17,950
| – | – | ﹤0.01% | 1689 |
|
|
2021
Q2 | $134K | Buy |
17,950
+1,000
| +6% | +$7.47K | ﹤0.01% | 1602 |
|
|
2021
Q1 | $99K | Buy |
+16,950
| New | +$99K | ﹤0.01% | 1550 |
|